These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 38281467)

  • 1. OMERACT 2023 Systemic Lupus Erythematosus Special Interest Group: Winnowing and Binning Preliminary Candidate Domains for the Core Outcome Set.
    Nielsen W; Strand V; Simon LS; Parodis I; Kim AHJ; Desai M; Enman Y; Wallace D; Chaichian Y; Navarra S; Aranow C; MacKay M; Trotter K; Tayer-Shifman OE; Duarte-Garcia A; Shan Tam L; Ugarte-Gil MF; PonsEstel GJ; Reynolds JA; Nikpour M; Hoi A; Romero-Diaz J; Papachristos D; Aggarwal A; Mok CC; Fujio K; Ramsey-Goldman R; Howe A; Kia BN; Bonilla D; Thumboo J; Mosca M; Aringer M; Johnson SR; Drucker AM; Morand E; Bruce I; Touma Z;
    Semin Arthritis Rheum; 2024 Apr; 65():152380. PubMed ID: 38281467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. OMERACT systemic lupus erythematosus domain survey.
    Nielsen W; Strand V; Simon L; Pinsker E; Bonilla D; Morand E; Thumboo J; Aringer M; Mosca M; Bruce I; Parodis I; Kim A; Desai M; Enman Y; Shea B; Wallace DJ; Chaichian Y; Navarra S; Aranow C; Mackay M; Trotter K; Tayer-Shifman OE; Duarte-García A; Shan Tam L; Ugarte-Gil MF; Pons-Estel GJ; Reynolds JA; Nikpour M; Hoi A; Romero-Diaz J; Aggarwal A; Mok CC; Fujio K; Ramsey-Goldman R; Gladman DD; Arnaud L; Bultink IEM; Ruiz-Irastorza G; Inês LS; Appenzeller S; Dobrowolski C; Clarke AE; Kamen DL; Barraclough M; Tani C; Gómez-Puerta JA; Werth VP; Katz P; Nowrouzi-Kia B; Johnson SR; Drucker AM; Touma Z;
    Semin Arthritis Rheum; 2024 Oct; 68():152520. PubMed ID: 39106780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Preliminary Core Domain Set for Clinical Trials of Shoulder Disorders: A Report from the OMERACT 2016 Shoulder Core Outcome Set Special Interest Group.
    Buchbinder R; Page MJ; Huang H; Verhagen AP; Beaton D; Kopkow C; Lenza M; Jain NB; Richards B; Richards P; Voshaar M; van der Windt D; Gagnier JJ;
    J Rheumatol; 2017 Dec; 44(12):1880-1883. PubMed ID: 28089972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consensus on the definitions and descriptions of the domains of the OMERACT Core Outcome Set for shared decision making interventions in rheumatology trials.
    Décary S; de Wit M; Naye F; Barton JL; Fraenkel L; Li LC; Brooks P; Stacey D; Maxwell LJ; Campbell W; Hofstetter C; Voshaar M; Meara A; Christensen R; Boonen A; Suarez-Almazor ME; Meade T; March L; Jull JE; Alten R; Morgan EM; Stewart Hazlewood G; Barber CEH; Guillemin F; El-Miedany Y; Mittoo S; Robertson TW; Bartlett SJ; Singh JA; Mannion M; Nasef SI; Boel A; Adebajo A; Arnaud L; Gill TK; Moholt E; Burt J; Jayatilleke A; Hmamouchi I; Berthelsen DB; Blanco FJ; Mather K; Maharaj A; Sharma S; Caso F; Beaton D; Shea B; Fong C; Fernandez AP; Mackie S; Nikiphorou E; Jones A; Greer-Smith R; Sloan VS; Akpabio A; Strand V; Lee RR; Umaefulam V; Monti S; Abaza N; Schultz G; Stones S; Gossec L; Nielsen SM; Cavallo S; Srinivasalu H; Constien D; Evans V; Tugwell P; Toupin-April K
    Semin Arthritis Rheum; 2024 Apr; 65():152381. PubMed ID: 38306813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consensus of the definitions of the OMERACT glucocorticoid impact core domain set for people with rheumatic and musculoskeletal diseases.
    Lyne SA; Yip K; Vasiliou VS; Katz DA; Richards P; Tieu J; Black RJ; Bridgewater S; Palmowski A; Beaton D; Maxwell LJ; Robson JC; Mackie SL; Goodman SM; Hill CL
    Semin Arthritis Rheum; 2024 Feb; 64():152338. PubMed ID: 38134623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developing a core outcome set for foot and ankle disorders in rheumatic and musculoskeletal diseases: A scoping review and report from the OMERACT 2022 foot and ankle special interest group session.
    Chapman LS; Jones J; Redmond AC; Flurey CA; Richards P; Hofstetter C; Smith TO; Arnold JB; Hannan MT; Maxwell LJ; Menz HB; Shea B; Golightly YM; Tugwell P; Beaton D; Conaghan PG; Helliwell PS; Siddle HJ
    Semin Arthritis Rheum; 2023 Aug; 61():152210. PubMed ID: 37156170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for Updating the Core Domain Set of Outcome Measures for Juvenile Idiopathic Arthritis: Report from a Special Interest Group at OMERACT 2016.
    Morgan EM; Riebschleger MP; Horonjeff J; Consolaro A; Munro JE; Thornhill S; Beukelman T; Brunner HI; Creek EL; Harris JG; Horton DB; Lovell DJ; Mannion ML; Olson JC; Rahimi H; Gallo MC; Calandra S; Ravelli A; Ringold S; Shenoi S; Stinson J; Toupin-April K; Strand V; Bingham CO
    J Rheumatol; 2017 Dec; 44(12):1884-1888. PubMed ID: 28811355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The OMERACT Core Domain Set for Clinical Trials of Shoulder Disorders.
    Ramiro S; Page MJ; Whittle SL; Huang H; Verhagen AP; Beaton DE; Richards P; Voshaar M; Shea B; van der Windt DA; Kopkow C; Lenza M; Jain NB; Richards B; Hill C; Gill TK; Koes B; Foster NE; Conaghan PG; Smith T; Malliaras P; Roe Y; Gagnier JJ; Buchbinder R
    J Rheumatol; 2019 Aug; 46(8):969-975. PubMed ID: 30709947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving benefit-harm assessment of glucocorticoid therapy incorporating the patient perspective: The OMERACT glucocorticoid core domain set.
    Tieu J; Cheah JT; Black RJ; Christensen R; Ghosh N; Richards P; Robson J; Shea B; Simon LS; Singhi JA; Tugwell P; Boers M; Garibay MAA; Campochiaro C; Decary S; de Witt M; Fernandez AP; Keen HI; King L; Hinojosa-Azaola A; Hofstetter C; Gaydukova I; George MD; Gupta L; Lyne S; Makol A; Mukhtyar C; Oo WM; Petri M; Pisaniello HL; Sattui SE; Russell O; Teixeira V; Toupin-April K; Uhunmwangho C; Whitstock M; Yip K; Mackie SL; Goodman SM; Hill CL
    Semin Arthritis Rheum; 2021 Oct; 51(5):1139-1145. PubMed ID: 34253398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endpoints: consensus recommendations from OMERACT IV. Outcome Measures in Rheumatology.
    Strand V; Gladman D; Isenberg D; Petri M; Smolen J; Tugwell P
    Lupus; 2000; 9(5):322-7. PubMed ID: 10878722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining domains: developing consensus-based definitions for foundational domains in OMERACT core outcome sets.
    Maxwell LJ; Jones C; Bingham CO; Boers M; Boonen A; Choy E; Christensen R; Conaghan PG; D'Agostino MA; Doria AS; Grosskleg S; Hill CL; Hofstetter C; Horgan B; Kroon F; Leung YY; Mackie S; Meara A; Shea BJ; Simon LS; Touma Z; Tugwell P; Wells GA; Beaton DE
    Semin Arthritis Rheum; 2024 Jun; 66():152423. PubMed ID: 38460282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient outcomes in longitudinal observational studies (POLOS) of rheumatoid arthritis: Determining the OMERACT core domain set.
    Benavent D; Carmona L; Lopez-Olivo MA; Hill CL; Westrich-Robertson T; Goel N; Strand V; Shea B; Grosskleg S; Leong A; Hofstetter C; Bingham C; Meyer D; Constien D; Berthelsen DB; Schultz G; de Groot I; Weiner J; Mather K; de Wit M; Böhm P; Cembalo SM; Tugwell P; Bruera S; Suarez-Almazor ME
    Semin Arthritis Rheum; 2024 Feb; 64():152343. PubMed ID: 38118370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Core Domain Set Selection According to OMERACT Filter 2.1: The OMERACT Methodology.
    Maxwell LJ; Beaton DE; Shea BJ; Wells GA; Boers M; Grosskleg S; Bingham CO; Conaghan PG; D'Agostino MA; de Wit M; Gossec L; March L; Simon LS; Singh JA; Strand V; Tugwell P
    J Rheumatol; 2019 Aug; 46(8):1014-1020. PubMed ID: 30770502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishing an Updated Core Domain Set for Studies in Juvenile Idiopathic Arthritis: A Report from the OMERACT 2018 JIA Workshop.
    Morgan EM; Munro JE; Horonjeff J; Horgan B; Shea B; Feldman BM; Clairman H; Bingham CO; Thornhill S; Strand V; Alongi A; Magni-Manzoni S; van Rossum MAJ; Vesely R; Vojinovic J; Brunner HI; Harris JG; Horton DB; Lovell DJ; Mannion M; Rahimi H; Ravelli A; Ringold S; Ruperto N; Schrandt MS; Shenoi S; Shiff NJ; Toupin-April K; Tzaribachev N; Weiss P; Consolaro A
    J Rheumatol; 2019 Aug; 46(8):1006-1013. PubMed ID: 30770499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of Consensus Methodology to Determine Candidate Items for Systemic Lupus Erythematosus Classification Criteria.
    Johnson SR; Khanna D; Daikh D; Cervera R; Costedoat-Chalumeau N; Gladman DD; Hahn BH; Hiepe F; Sánchez-Guerrero J; Massarotti E; Boumpas DT; Costenbader KH; Jayne D; Dörner T; Kamen DL; Mosca M; Ramsey-Goldman R; Smolen JS; Wofsy D; Aringer M
    J Rheumatol; 2019 Jul; 46(7):721-726. PubMed ID: 30554156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toward the Development of a Core Set of Outcome Domains to Assess Shared Decision-making Interventions in Rheumatology: Results from an OMERACT Delphi Survey and Consensus Meeting.
    Toupin-April K; Barton J; Fraenkel L; Li LC; Brooks P; De Wit M; Stacey D; Légaré F; Meara A; Shea B; Lyddiatt A; Hofstetter C; Gossec L; Christensen R; Scholte-Voshaar M; Suarez-Almazor ME; Boonen A; Meade T; March L; Pohl C; Jull JE; Sivarajah S; Campbell W; Alten R; Karuranga S; Morgan E; Kaufman J; Hill S; Maxwell LJ; Welch V; Beaton D; El-Miedany Y; Tugwell PS
    J Rheumatol; 2017 Oct; 44(10):1544-1550. PubMed ID: 28765239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishing a core domain set to measure rheumatoid arthritis flares: report of the OMERACT 11 RA flare Workshop.
    Bykerk VP; Lie E; Bartlett SJ; Alten R; Boonen A; Christensen R; Furst DE; Hewlett S; Leong AL; Lyddiatt A; March L; May JE; Montie P; Orbai AM; Pohl C; Scholte Voshaar M; Woodworth T; Bingham CO; Choy EH
    J Rheumatol; 2014 Apr; 41(4):799-809. PubMed ID: 24584927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards development of core domain sets for short term and long term studies of calcium pyrophosphate crystal deposition (CPPD) disease: A framework paper by the OMERACT CPPD working group.
    Cai K; Fuller A; Zhang Y; Hensey O; Grossberg D; Christensen R; Shea B; Singh JA; McCarthy GM; Rosenthal AK; Filippou G; Taylor WJ; Diaz-Torne C; Stamp LK; Edwards NL; Pascart T; Becce F; Nielsen SM; Tugwell P; Beaton D; Abhishek A; Tedeschi SK; Dalbeth N
    Semin Arthritis Rheum; 2021 Aug; 51(4):946-950. PubMed ID: 34140183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The OMERACT-OARSI Core Domain Set for Measurement in Clinical Trials of Hip and/or Knee Osteoarthritis.
    Smith TO; Hawker GA; Hunter DJ; March LM; Boers M; Shea BJ; Christensen R; Guillemin F; Terwee CB; Williamson PR; Dodd S; Roos EM; Loeser RF; Schnitzer TJ; Kloppenburg M; Neogi T; Ladel CH; Kalsi G; Kaiser U; Buttel TW; Ashford AE; Mobasheri A; Arden NK; Tennant A; Hochberg MC; de Wit M; Tugwell P; Conaghan PG
    J Rheumatol; 2019 Aug; 46(8):981-989. PubMed ID: 30647185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The American College of Rheumatology response criteria for systemic lupus erythematosus clinical trials: measures of overall disease activity.
    American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Response Criteria
    Arthritis Rheum; 2004 Nov; 50(11):3418-26. PubMed ID: 15529383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.